Leading CRDMO Syngene is a Triple Category Award winner in the 2024 Pharmaceutical Technology Excellence Awards.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

View the full release here: "I'm excited to welcome Alastair to Chemify to help us with building and scaling our ability to ...

Standard Glass Lining shares made a strong start on the bourses today, listing at a 26% premium on the BSE and 23% on the NSE ...

( MENAFN - KNN India) New Delhi, Jan 10 (KNN) Fabtech Technologies Cleanrooms Ltd marked a Stellar debut on the BSE SME ...

BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic ...

Pharmaceuticals and vector-control programmes have greatly diminished the once-widespread disease, but sustained effort will ...

Centessa is rapidly advancing a potential best-in-class and first-in-class portfolio of orexin receptor 2 (OX2R) agonists with a robust series of clinical milestones anticipated this year,” said ...

In the realm of industrial valve manufacturing few entities stand out as innovators and pioneers A vital component in countless industries from oil and gas to pharmaceuticals valves are essential for ...

GC Green Cross recently announced on the 10th the launch of its anti-inflammatory pain reliever "Teksan RAY" in a large ...

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines ...